fenofibrate has been researched along with Hyperchylomicronemia Late Onset in 15 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate-based treatment was associated with improved insulin sensitivity." | 5.16 | Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose. ( Buldak, L; Dulawa-Buldak, A; Labuzek, K; Okopien, B, 2012) |
| " Lipid profiles, physical and laboratory investigations for adverse effects were assessed." | 2.71 | [Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia]. ( Chen, H; Luo, Y; Ren, JY, 2005) |
| " Both treatment regimens were safe and well tolerated." | 2.71 | Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia. ( Abby, S; Jones, M; McKenney, J, 2005) |
| "Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides." | 1.33 | A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas. ( Chang, SH; Chung, SI; Hahm, JR; Jung, JH; Jung, TS; Kim, DR; Kim, MA; Lee, GW; Park, JR; Park, KJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz Rodríguez, Á | 1 |
| Rehman, HU | 1 |
| Buldak, L | 1 |
| Dulawa-Buldak, A | 1 |
| Labuzek, K | 1 |
| Okopien, B | 1 |
| Nagra, PK | 1 |
| Ho, AC | 1 |
| Dugan, JD | 1 |
| Zeman, M | 1 |
| Zák, A | 1 |
| Vecka, M | 1 |
| Romaniv, S | 1 |
| Ren, JY | 1 |
| Chen, H | 1 |
| Luo, Y | 1 |
| Park, JR | 1 |
| Jung, TS | 1 |
| Jung, JH | 1 |
| Lee, GW | 1 |
| Kim, MA | 1 |
| Park, KJ | 1 |
| Kim, DR | 1 |
| Chang, SH | 1 |
| Chung, SI | 1 |
| Hahm, JR | 1 |
| McKenney, J | 1 |
| Jones, M | 1 |
| Abby, S | 1 |
| Kayikçioğlu, M | 1 |
| Ozerkan, F | 1 |
| Soydan, I | 1 |
| Giral, P | 1 |
| Bruckert, E | 1 |
| Jacob, N | 1 |
| Chapman, MJ | 1 |
| Foglietti, MJ | 1 |
| Turpin, G | 1 |
| Liamis, G | 1 |
| Kakafika, A | 1 |
| Bairaktari, E | 1 |
| Miltiadous, G | 1 |
| Tsimihodimos, V | 1 |
| Goudevenos, J | 1 |
| Achimastos, A | 1 |
| Elisaf, M | 1 |
| Ol'binskaia, LI | 1 |
| Vartanova, OA | 1 |
| Aleksandrovskaia, TN | 1 |
| Shaldaeva, VV | 1 |
| Seidehamel, RJ | 1 |
| Goldberg, AC | 1 |
| Schonfeld, G | 1 |
| Feldman, EB | 1 |
| Ginsberg, HN | 1 |
| Hunninghake, DB | 1 |
| Insull, W | 1 |
| Knopp, RH | 1 |
| Kwiterovich, PO | 1 |
| Mellies, MJ | 1 |
| Pickering, J | 1 |
| Gariot, P | 1 |
| Barrat, E | 1 |
| Drouin, P | 1 |
| Genton, P | 1 |
| Pointel, JP | 1 |
| Foliguet, B | 1 |
| Kolopp, M | 1 |
| Debry, G | 1 |
9 trials available for fenofibrate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Topics: Adipokines; Adiponectin; Adult; Aged; Analysis of Variance; Atorvastatin; Biomarkers; Blood Glucose; | 2012 |
[Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].
Topics: Adult; Aged; Anticholesteremic Agents; Clofibric Acid; Drug Therapy, Combination; Female; Fenofibrat | 2003 |
[Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].
Topics: Drug Therapy, Combination; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type V; Hypolipidemic A | 2005 |
Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia.
Topics: Allylamine; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Fenof | 2005 |
Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hydroxymethylg | 1999 |
Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia.
Topics: Atorvastatin; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; | 2001 |
Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Clofibric Acid; Drug Administration Schedule; D | 2002 |
Fenofibrate in type IV and type V hyperlipoproteinemia.
Topics: Cholesterol; Double-Blind Method; Female; Fenofibrate; Gastrointestinal Diseases; Humans; Hyperlipop | 1989 |
Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.
Topics: Adolescent; Adult; Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Fenofib | 1989 |
6 other studies available for fenofibrate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
[The fixed combination of pravastatin and fenofibrate: what can it provide?].
Topics: Atherosclerosis; Cardiovascular Diseases; Drug Combinations; Dyslipidemias; Fenofibrate; Humans; Hyd | 2014 |
The work-up for mixed hyperlipidemia: a case study.
Topics: Adult; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Electrophoresis; Fenofibrate; Fluor | 2012 |
Lipemia retinalis associated with branch retinal vein occlusion.
Topics: Combined Modality Therapy; Diet Therapy; Exercise Therapy; Female; Fenofibrate; Humans; Hyperlipopro | 2003 |
A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.
Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fenofibrate; Humans; Hyperlipidemias; Hy | 2005 |
[The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl].
Topics: Arteriosclerosis; Drug Evaluation; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperl | 1991 |
Morphometric study of human hepatic cell modifications induced by fenofibrate.
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; | 1987 |